Up to 75 million more doses to EU in Q2
AstraZeneca's COVID-19 vaccine granted conditional marketing authorisation
New chapter in the COVID-19 vaccine saga
Company pulls out of scheduled discussion, EU says
EU needs more COVID-19 vaccines
Good things can come from the east
British vaccine soon available through EU anyway
If it’s good in the UK, it’s good enough for us
They have received marketing authorisation in various countries
AstraZeneca files for conditional marketing authorisation
Plans to buy up to 300 million doses
Mass production may start in Q1 2021 at the earliest
Concludes talks with sixth manufacturer
British drugmaker to supply 300 mn doses